4-androstene-3,17-diol has been researched along with dehydroepiandrosterone sulfate in 1 studies
Studies (4-androstene-3,17-diol) | Trials (4-androstene-3,17-diol) | Recent Studies (post-2010) (4-androstene-3,17-diol) | Studies (dehydroepiandrosterone sulfate) | Trials (dehydroepiandrosterone sulfate) | Recent Studies (post-2010) (dehydroepiandrosterone sulfate) |
---|---|---|---|---|---|
13 | 1 | 2 | 4,127 | 412 | 946 |
Protein | Taxonomy | 4-androstene-3,17-diol (IC50) | dehydroepiandrosterone sulfate (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hammond, CJ; Hysi, PG; Vehof, J | 1 |
1 other study(ies) available for 4-androstene-3,17-diol and dehydroepiandrosterone sulfate
Article | Year |
---|---|
A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Androgens; Androstenediols; Androsterone; Biomarkers; Cohort Studies; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Dry Eye Syndromes; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Metabolome; Middle Aged; Risk Factors; Surveys and Questionnaires | 2017 |